Literature DB >> 10951532

Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly diagnosed never-treated hypertensives.

A M Grandi1, P Zanzi, E Piantanida, G Gaudio, A Bertolini, L Guasti, A Venco.   

Abstract

OBJECTIVE: To evaluate the influence of obesity, per se or associated with hypertension, on left ventricular (LV) diastolic function. PATIENTS: Thirty-two obese newly-diagnosed never-treated hypertensives; 32 obese normotensives matched for age, sex and BMI with hypertensives; 32 lean newly diagnosed never-treated hypertensives and 32 lean normotensives, matched for age, sex and 24 h blood pressure (BP) with the obese subjects.
METHODS: Twenty-four-hour ambulatory blood pressure monitoring and digitized M-mode LV echocardiograms. PARAMETERS EVALUATED: Twenty-four-hour, day-time and night-time BP and heart rate, percentage nocturnal BP fall; LV end-diastolic diameter index, septal and posterior wall thickness, LV mass index, peak shortening and lengthening rate of LV diameter, peak thinning rate of LV posterior wall.
RESULTS: A main effect was found for obesity on LV diameter and LV mass and for hypertension on LV mass; LV systolic function was normal in all the subjects and similar among the four groups; LV diastolic function was significantly reduced in both obese groups with respect to lean ones. This difference persisted after correction of diastolic parameters for 24 h BP and heart rate, LV diameter and LV mass index and disappeared only after correction for body mass index. This latter was inversely related with diastolic parameters only in the obese groups.
CONCLUSIONS: Obesity is associated with a preclinical impairment of LV diastolic function in both normotensives and hypertensives; the diastolic impairment is independent of haemodynamic factors, such as 24 h BP and heart rate, and bears no relation to LV geometry in normotensives and only little relation in hypertensives, having therefore to be ascribed to obesity itself.

Entities:  

Mesh:

Year:  2000        PMID: 10951532     DOI: 10.1038/sj.ijo.0801261

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  9 in total

1.  Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension.

Authors:  Viktor Persic; Alen Ruzic; Bojan Miletic; Sanja Balen; Zeljko Jovanovic; Aleksandar Vcev; Sanjin Racki; Bozidar Vujicic
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats.

Authors:  Leanne Groban; Hao Wang; Frederico S M Machado; Aaron J Trask; Stephen B Kritchevsky; Carlos M Ferrario; Debra I Diz
Journal:  Cardiovasc Endocrinol       Date:  2012-09-01

3.  Left atrial volume and index by multi-detector computed tomography: comprehensive analysis from predictors of enlargement to predictive value for acute coronary syndrome (ROMICAT study).

Authors:  Quynh A Truong; Fabian Bamberg; Amir A Mahabadi; Michael Toepker; Hang Lee; Ian S Rogers; Sujith K Seneviratne; Christopher L Schlett; Thomas J Brady; John T Nagurney; Udo Hoffmann
Journal:  Int J Cardiol       Date:  2009-07-16       Impact factor: 4.164

4.  Major weight loss prevents long-term left atrial enlargement in patients with morbid and extreme obesity.

Authors:  Carolina A Garza; Patricia A Pellikka; Virend K Somers; Michael G Sarr; James B Seward; Maria L Collazo-Clavell; Elise Oehler; Francisco Lopez-Jimenez
Journal:  Eur J Echocardiogr       Date:  2008-04-04

Review 5.  Is there a cardiomyopathy of obesity?

Authors:  Theophilus Owan; Sheldon E Litwin
Journal:  Curr Heart Fail Rep       Date:  2007-12

6.  Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment.

Authors:  Bindu Garg; Nirmal Yadav; Harsha Vardhan; A K De
Journal:  J Clin Diagn Res       Date:  2013-08-01

Review 7.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

8.  Impact of type 2 diabetes on cardiorespiratory function and exercise performance.

Authors:  Joanie Caron; Gregory R duManoir; Lawrence Labrecque; Audrey Chouinard; Annie Ferland; Paul Poirier; Sylvie Legault; Patrice Brassard
Journal:  Physiol Rep       Date:  2017-02-27

9.  Cardiac remodeling in patients with childhood-onset craniopharyngioma-results of HIT-Endo and KRANIOPHARYNGEOM 2000/2007.

Authors:  Panjarat Sowithayasakul; Leona Katharin Buschmann; Svenja Boekhoff; Hermann L Müller
Journal:  Eur J Pediatr       Date:  2021-01-18       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.